Brazil Vitamin K2 Market Forecast to 2028 - Country Analysis by Product, Dosage Forms, Source, and Application

The Brazil vitamin K2 market is projected to reach US$ 9.81 million by 2028 from US$ 1.59 million in 2022; it is estimated to grow at a CAGR of 35.6% from 2023 to 2028. The growth of the Brazil vitamin K2 market is attributed to the increasing prevalence of CVD and growing cases of osteoporosis bone deformation in adults and newborns. However, a lack of awareness might hamper the growth.

Osteoporosis is an increasingly common health issue affecting adults and babies, a disorder marked by weakening and fragile bones. According to a Research Gate study in 2022, osteoporosis is prevalent in 6-33% of Brazilians. Medical professionals are concerned about the surge in osteoporosis-related bone distortion cases. As per recent studies from Research Gate, the potential advantages of vitamin K2 include supporting bone health and possibly reducing the consequences of osteoporosis.

Vitamin K2 is a lesser-known vitamin K essential for maintaining healthy calcium metabolism and bone density. It stimulates proteins that transfer calcium from the bloodstream into the bones to ensure adequate mineralization and strength. The nutrient aid in avoiding osteoporosis-related bone fractures and deformities by improving calcium absorption. Adult osteoporosis cases frequently result from hormonal changes, age-related bone loss, or inadequate food intake. Vitamin K2 supplementation has demonstrated promising outcomes in enhancing bone mineral density and lowering fracture risk among adults. In addition, women are the main target for bone health products due to their higher incidence of osteoporosis. The increasing incidence of osteoporosis-related difficulties continues to be a key focus for functional foods and supplements, such as calcium and vitamin D are the primary components supporting bone health. Calcium is the main mineral component of bones, while vitamin helps with calcium absorption changes. However, as consumers are becoming more aware of the benefits of vitamin K2, its availability in foods and supplements is rising. In addition, it has been proposed that vitamin K2 aid in reducing the activity of osteoclast cells, which are responsible for bone deterioration, further protecting bone integrity.

Newborns can develop osteoporosis, especially preterm babies. They are more prone to fractures since their bones are immature and weak. Vitamin K2 improves bone growth and lessens the likelihood of bone abnormalities in the therapy regimens for these infants. Their skeletal development is accelerated by vitamin K2 supplementation, which supports the naturally occurring processes during the early stages of life. Thus, the growing number of adult and neonatal incidences of osteoporosis-related bone abnormalities creates the urgent need for efficient preventative measures and treatment approaches. Hence, vitamin K2 supplementation acts as a potential supplementary therapy that help with calcium metabolism, bone mineralization, and the prevention of fractures. All these factors are driving the Brazil vitamin K2 market growth.

The Brazil vitamin K2 market is segmented on the basis of product, dosage forms, source, and application. Based on product, the Brazil vitamin K2 market is further segmented into MK-4, MK-7, and combination drugs. In 2022, the MK-7 segment held the largest market share of the Brazil vitamin K2 market. Moreover, the same segment is estimated to grow at a significant CAGR of during the forecast period.

Based on dosage forms, the Brazil vitamin K2 market is segmented into capsules and tablets, powder, and oils. In 2022, the powder segment held the larger market share by dosage forms. Moreover, the same segment is estimated to grow at a significant CAGR during the forecast period. Based on source, the market is classified into natural and synthetic. In 2022, the natural segment held the largest share of the market. Further, the same segment is expected to grow at the fastest CAGR during the coming years. Likewise, based on application, the market is segmented into pharmaceuticals, nutraceuticals and food, and others. In 2022, the pharmaceuticals segment held the largest share of the market. However, the nutraceuticals and food segment are estimated to grow at a significant CAGR during the forecast period.

A few of the major primary and secondary sources associated with this report on the Brazil vitamin K2 market are the Centers for Disease Control and Prevention (CDC), National Health Regulatory Agency (“ANVISA”), Instituto Brasileiro de Geografia e Estatística (IBGE), and International Trade Administration, Brazil.